Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis

Fig. 1

Site-targeting drugs and NPs for different stages of atherothrombosis. NPs can be made from different biomaterials and various formats of antibodies can be used to target and disrupt the atherothrombosis stages of endothelial dysfunction, neovascularization, lipid metabolism, recruitment of leukocytes, phagocytosis of macrophages, and formation of foam cells, along with inefficient efferocytosis, vascular SMC proliferation, and thrombosis

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us